Vic online event: Biochemical engineering


Event details

Thursday 4 June 2020

6pm start
Join Zoom Meeting
Meeting ID: 872 5125 5015
Password: 050625


Dr Richard Hannink FTSE
Victorian Division Committee Events Coordinator

Elvira Copur
Fellowship Manager
03 9864 0910

The Victorian Division invites you to a Zoom conversation on Biochemical Engineering with expert guest speakers Professor Sandra Kentish FTSE and Professor Karen Hapgood.

Professor Sandra Kentish, FTSE
Head of School, Chemical & Biomedical Engineering, University of Melbourne

Providing Value to the Australian Dairy Industry

The dairy industry is Australia’s fourth largest rural industry, generating $4.4billion in farmgate value in 2018-19.

However, it is also an industry in transition. As ongoing drought has reduced fresh milk volumes, both dairy farms and dairy processors have consolidated.

Conversely, the export value of the industry remains strong, reflecting sales of value-added dairy products such as infant formula and cheese.


The ARC Dairy Innovation Hub has been part of this journey, helping our processing partners to develop new products, to conserve water and to reduce waste. This presentation will give an overview of some of the work we have undertaken within the Dairy Innovation Hub over the last five years and the path forward for the industry.

Biography: Sandra Kentish is a Redmond Barry Distinguished Professor and Head of the School of Chemical and Biomedical Engineering at The University of Melbourne. She has broad interests in industrial separations, particularly the use of membrane technology for energy, food and water applications. She is a Project Leader within the ARC Dairy Innovation Research Hub, a researcher within the Future Fuels CRC and sits on the EPA Victoria Science, Engineering and Health Committee.

Professor Kentish was selected as one of Australia’s Most Innovative Engineers by Engineers Australia in 2017 and as a Woman of Influence by the Australian Financial Review in 2018. She was elected to the Australian Academy of Technology and Engineering in 2019.

Professor Karen Hapgood 
Executive Dean, Faculty of Science, Engineering & Built Environment
Deakin University 

The future of 3D printing in the pharmaceutical industry

Pharmaceutical manufacturing of tablets is a currently a very traditional but robust process, ideal for producing large volumes of identical tablets at low cost.

Interest in developing personalised medicines, where the dose and medicine is custom produced for the patient, is growing.

Karen Hapgood

New additive manufacturing and 3D printing technologies offer a potential way to achieve this. This talk will give an introduction to 3D printing and current research on its applications in pharmaceutical manufacturing, and the role that Australia can play in bringing more advanced manufacturing to one of our important export markets.

Biography: Professor Karen Hapgood is Executive Dean of the faculty of Science, Engineering & Built Environment at Deakin University.  Her career has criss-crossed between industry and academia. After graduating from chemical engineering and working for 2.5 years as a control engineer, she returned  to UQ to complete her PhD on powder technology.

She worked for Merck & Co in the US and Australia for 5 years, before joining Monash University.  She became the Head of the Department of Chemical Engineering at Monash in 2012, and moved to Deakin University in Geelong in 2017 as the Head of School of Engineering.

In July 2018, she became the Executive Dean of the Faculty of Science, Engineering and the Built Environment. Her professional research interests include powder technology, pharmaceutical manufacturing, 3D printing, and promoting diversity in engineering.